Advertisement
Canada markets close in 5 hours 26 minutes
  • S&P/TSX

    21,951.60
    +66.22 (+0.30%)
     
  • S&P 500

    5,101.16
    +52.74 (+1.04%)
     
  • DOW

    38,279.04
    +193.24 (+0.51%)
     
  • CAD/USD

    0.7318
    -0.0005 (-0.07%)
     
  • CRUDE OIL

    83.74
    +0.17 (+0.20%)
     
  • Bitcoin CAD

    88,138.69
    +1,191.62 (+1.37%)
     
  • CMC Crypto 200

    1,345.06
    -51.48 (-3.69%)
     
  • GOLD FUTURES

    2,353.40
    +10.90 (+0.47%)
     
  • RUSSELL 2000

    2,002.13
    +21.01 (+1.06%)
     
  • 10-Yr Bond

    4.6550
    -0.0510 (-1.08%)
     
  • NASDAQ

    15,902.35
    +290.59 (+1.86%)
     
  • VOLATILITY

    15.25
    -0.12 (-0.78%)
     
  • FTSE

    8,135.24
    +56.38 (+0.70%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6842
    +0.0021 (+0.31%)
     

What Drove Down Rite Aid’s Fiscal 4Q18 Sales?

What Drove Down Rite Aid’s Fiscal 4Q18 Sales?

As we saw in the previous part of this series, Rite Aid (RAD) reported an 8.6% YoY (year-over-year) decline in its fiscal 4Q18 revenues from continuing operations to $5.4 billion. Its Retail Pharmacy segment, which includes prescription drugs, health and beauty products, and personal care items, saw its revenue fall 10.1% to $4 billion. Same-store sales from continuing operations fell 1.7% YoY during the quarter, driven by a 2.3% decline in pharmacy sales and a 0.6% fall in front-end sales.